MFDS — authorised 15 May 2013
- Marketing authorisation holder: BAYER HLTHCARE
- Status: likely_approved
🇰🇷 Xofigo in South Korea
MFDS authorised Xofigo on 15 May 2013
Marketing authorisation
Xofigo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Xofigo approved in South Korea?
Yes. MFDS authorised it on 15 May 2013.
Who is the marketing authorisation holder for Xofigo in South Korea?
BAYER HLTHCARE holds the South Korean marketing authorisation.